Biostar Pharmaceuticals, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, the company reported sales of $801,627 against $6,908,747 a year ago. Loss from operations was $668,518 against $889,998 a year ago. Loss before income taxes was $678,566 against $638,975 a year ago. Net loss was $620,341 or $0.28 per basic and diluted share against $160,104 or $0.07 per basic and diluted share a year ago. Net cash provided by operating activities was $342,822 against $2,835,026 a year ago.